£632.00
Estimated delivery Wed 28 Apr
Shipping is calculated in checkout
Shipping is calculated in checkout
WT-161 is a potent, selective, and bioavailable HDAC6 (histone deacetylase-6) inhibitor (IC₅₀ 0.40 nM). It is selective for HDAC6 over HDAC3 (IC₅₀ = 51.61 nM) and induces α-tubulin acetylation, an HDAC6-dependent process, with minimal effect on global lysine acetylation. WT161 inhibits growth of patient-derived multiple myeloma cell lines with IC₅₀ values ranging from 1.5 to 4.7 µM. WT161 enhances the cytotoxicity of bortezomib (Cat. No. 1846) and carfilzomib (Cat. No. 2385) against patient-derived multiple myeloma cells.
Product Type:
Biochemicals
CAS Number:
1206731-57-8
Storage Temp:
-20°C
Compound Purity:
≥98% by HPLC
Molecular Weight:
458.56
UNSPSC Code:
12352200
